Milan, Italy

Roberta Bozzella

USPTO Granted Patents = 4 


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Roberta Bozzella: Innovator in Oral Antimicrobial Pharmaceutical Compositions

Introduction

Roberta Bozzella is a distinguished inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of oral antimicrobial compositions. With a total of four patents to her name, Bozzella's work is focused on improving treatments for infections of the large intestine.

Latest Patents

Among her latest patents, Bozzella has developed oral pharmaceutical compositions with controlled and/or programmed release. These compositions contain at least one active ingredient that exhibits antimicrobial and/or anti-infectious activity, specifically targeting infections of the large intestine, particularly the colon. This innovative approach aims to enhance the effectiveness of treatments and improve patient outcomes.

Career Highlights

Roberta Bozzella has established herself as a key figure in her field through her innovative research and development efforts. Her work at Cosmo Technologies Limited has allowed her to push the boundaries of pharmaceutical science, contributing to advancements that have the potential to benefit many patients suffering from intestinal infections.

Collaborations

Throughout her career, Bozzella has collaborated with notable colleagues, including Mauro Ajani and Giuseppe Celasco. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of her work.

Conclusion

Roberta Bozzella's contributions to the field of oral antimicrobial pharmaceutical compositions highlight her dedication to innovation and improving healthcare solutions. Her patents reflect a commitment to addressing critical medical needs, making her a valuable asset in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…